Stryker Emerges As Buyer Of Howmedica; $1.9 Bil. Price Includes Heavy Debt
This article was originally published in The Gray Sheet
Executive Summary
Stryker's $1.9 bil. acquisition of Pfizer's Howmedica division will allow the firm to more quickly and efficiently penetrate the $10 bil. worldwide orthopedics market with new product introductions slated for release beginning in the year 2000, the company says.
You may also be interested in...
Stryker, Beckman Coulter Former CEOs Offer Insight On Acquisition Strategies
Maintaining sales relationships with existing customers after an acquisition is crucial to a successful integration, according to Stryker Chairman John Brown
Stryker, Beckman Coulter Former CEOs Offer Insight On Acquisition Strategies
Maintaining sales relationships with existing customers after an acquisition is crucial to a successful integration, according to Stryker Chairman John Brown
People In Brief
Polymedica CFO: Former Physicians Dialysis CFO Keith Jones assumes title at chronic disease management company Feb. 14. The move reunites Jones with Polymedica's new President & CEO Patrick Ryan; the duo co-founded Physicians Dialysis, where Ryan was CEO until DaVita purchased the company in September 2004 (1"The Gray Sheet" Oct. 4, 2004, p. 21). Prior to working at Physicians Dialysis, Jones worked as chief accounting officer/corporate controller for Renal Treatment Centers, which Renal Treatment Care purchased for $1.1 bil. in 1998. Jones replaces Fred Croninger, who becomes VP-finance & administration...